SensoDX II, LLC
Houston, United States · Founded 2016 · $868K raised
- Headquarters
- Houston, Texas
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2B
- Total Funding
- $868K
- Last Round
- $868K GrantJan 2017
- Rounds
- 1
About
SensoDX II develops programmable bio-nano-chip technology for point-of-care diagnostics across cardiac disease, cancer (oral, ovarian, prostate), trauma, and drugs of abuse. The platform integrates mobile health interfaces to deliver test results directly to patients and healthcare providers without centralized lab infrastructure.
Summary
SensoDX II, LLC is a Biotech company based in Houston, United States, founded in 2016. It has raised $868K in total across 1 round, most recently a $868K Grant round in Jan 2017. Investors include National Institutes of Health.
Funding History
Jan 2017
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/sensodx-ii-llc"><img src="https://indexed.vc/api/badge/company/sensodx-ii-llc" alt="SensoDX II, LLC on Indexed.vc" width="260" height="76" /></a>